경도인지장애

키워드

참고문헌 (72)

1. Jonker C, "Are memory complaints predictive for dementia? A review of clinical and population-based studies", Int J Geriatr Psychiatry, 15, pp.983~991 (2000)
2. Larrabee GJ, "Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function", Int Psychogeriatr, 6, pp.95~104 (1994)
3. Mitchell AJ, "The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta-analysis", Int J Geriatr Psychiatry, 23, pp.1191~1202 (2008)
4. Iliffe S, "Subjective memory problems", BMJ, 340, pp.c1425~ (2010)
5. Wang L, "Subjective memory deterioration and future dementia in people aged 65 and older", J Am Geriatr Soc, 52, pp.2045~2051 (2004)
6. Schofield PW, "The validity of new memory complaints in the elderly", Arch Neurol, 54, pp.756~759 (1997)
7. Roberts JL, "Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: A systematic review", Dement Geriatr Cogn Disord, 28, pp.95~109 (2009)
8. Ganguli M, "Can the DSM-5 framework enhance the diagnosis of MCI", Neurology, 81, pp.2045~2050 (2013)
9. Petersen RC, "Mild Cognitive Impairment: Aging to Alzheimer’s Disease", pp.15~40 (2003), Oxford university Press, Inc
10. Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
11. Dubois B, "Revising the definition of Alzheimer’s disease", Lancet Neurol, 9, pp.1118~1127 (2010)
12. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2013), American Psychiatric Association
13. Petersen RC, "Mild cognitive impairment: clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
14. Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
15. Gordon C, "Mild cognitive impairment", Expert Rev Neurother, 13, pp.1247~1261 (2013)
16. Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
17. Litvan I, "Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines", Mov Disord, 27, pp.349~356 (2012)
18. Graham JE, "Prevalence and severity of cognitive impairment with and without dementia in an elderly population", Lancet, 349, pp.1793~1796 (1997)
19. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2000), American Psychiatric Association
20. Jessen F, "AD dementia risk in late MCI, in early MCI, and in subjective memory impairment", Alzheimers Dement, 10, pp.76~83 (2014)
21. Libon DJ, "The heterogeneity of mild cognitive impairment: a neuropsychological analysis", J Int Neuropsychol Soc, 16, pp.84~93 (2010)
22. Roberts R, "Classification and epidemiology of MCI", Clin Geriatr Med, 29, pp.753~772 (2013)
23. Petersen RC, "Clinical practice. Mild cognitive impairment", N Engl J Med, 364, pp.2227~2234 (2011)
24. Plassman BL, "Prevalence of cognitive impairment without dementia in the United States", Ann Intern Med, 148, pp.427~434 (2008)
25. Petersen RC, "Prevalence of mild cognitive impairment is higher in men", Neurology, 75, pp.889~897 (2010)
26. Yaffe K, "Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus", JAMA Intern Med, 173, pp.1300~1306 (2013)
27. Farias ST, "Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts", Arch Neurol, 66, pp.1151~1157 (2009)
28. Palmer K, "Predictors of progression from mild cognitive impairment to Alzheimer disease", Neurology, 68, pp.1596~1602 (2007)
29. Kantarci K, "Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS", Neurology, 72, pp.1519~1525 (2009)
30. Koepsell TD, "Reversion from mild cognitive impairment to normal or near-normal cognition", Neurology, 79, pp.1591~1598 (2012)
31. Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force, "Lin JS", Agency for Healthcare Research and Quality, ~, pp.Report No:14-05198-EF-1 (2013)
32. Nasreddine ZS, "The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment", J Am Geriatr Soc, 53, pp.695~699 (2005)
33. Roalf DR, "Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging", Alzheimers Dement, 9, pp.529~537 (2013)
34. Langa KM, "The diagnosis and management of mild cognitive impairment: a clinical review", JAMA, 312, pp.2551~2561 (2014)
35. Teng E, "Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease", Alzheimer Dis Assoc Disord, 24, pp.348~353 (2010)
36. Brown PJ, "Alzheimer’s Disease Neuroimaging Initiative. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease", Arch Gen Psychiatry, 68, pp.617~626 (2011)
37. Steinman MA, "Managing medications in clinically complex elders", JAMA, 304, pp.1592~1601 (2010)
38. Shumaker SA, "Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women’s Health Initiative Memory Study", JAMA, 291, pp.2947~2958 (2004)
39. Liu H, "Optimal blood pressure for cognitive function: findings from an elderly African-American cohort study", J Am Geriatr Soc, 61, pp.875~881 (2013)
40. Yesavage JA, "Development and validation of a geriatric depression screening scale", J Psychiatr Res, 17, pp.37~49 (1983)
41. Cummings JL, "The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia", Neurology, 44, pp.2308~2314 (1994)
42. Jack CR, "Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease", Brain, 133, pp.3336~3348 (2010)
43. Clark CM, "Use of florbetapir-PET for imaging beta-amyloid pathology", JAMA, 305, pp.275~283 (2011)
44. Johnson KA, "Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging", Alzheimers Dement, 9, pp.S72~S83 (2013)
45. "Decision memo for beta a myloid positron emission tomography in dementia and neurodegenerative disease (CAG-00431N)" (2014)[URL]
46. Blennow K, "Cerebrospinal fluid protein biomarkers for Alzheimer's disease", NeuroRx, 1, pp.213~225 (2004)
47. Maruyama M, "Cerebrospinal fluid amyloid beta (1-42) levels in the mild cognitive impairment stage of Alzheimer’s disease", Exp Neurol, 172, pp.433~436 (2001)
48. Mattsson N, "CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment", JAMA, 302, pp.385~393 (2009)
49. Buchhave P, "Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia", Arch Gen Psychiatry, 69, pp.98~106 (2012)
50. Ritchie C, "Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)", Cochrane Database Syst Rev, pp.CD008782~ (2014)
51. Graff-Radford NR, "Association of low plasma Abeta42", Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer’s disease, 2007, pp.64, 354~362
52. Forlenza OV, "Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease", Rev Bras Psiquiatr, 35, pp.284~294 (2013)
53. Forlenza OV, "Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment", World J Biol Psychiatry, 11, pp.774~780 (2010)
54. Forlenza OV, "Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease", J Psychiatr Res, 45, pp.220~224 (2011)
55. Seo SW, "Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment", Neuroimage, 36, pp.289~297 (2007)
56. Ferreira LK, "Neurostructural predictors of Alzheimer’s disease: a meta-analysis of VBM studies", Neurobiol Aging, 32, pp.1733~1741 (2011)
57. Drzezga A, "Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG-PET", J Nucl Med, 46, pp.1625~1632 (2005)
58. Rowe CC, "Imaging beta-amyloid burden in aging and dementia", Neurology, 68, pp.1718~1725 (2007)
59. Russ TC, "Cholinesterase inhibitors for mild cognitive impairment", Cochrane Database Syst Rev, pp.CD009132~ (2012)
60. Dubois B, "Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease", Alzheimer Dement, 11, pp.1041~1049 (2015)
61. Bosch J, "Use of ramipril in preventing stroke: double blind randomized trial", BMJ, 324, pp.699~702 (2002)
62. Vermeer SE, "Silent brain infarcts and the risk of dementia and cognitive decline", N Engl J Med, 348, pp.1215~1222 (2003)
63. Schneider JA, "The neuropathology of probable Alzheimer disease and mild cognitive impairment", Ann Neurol, 66, pp.200~208 (2009)
64. Kernan WN, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2014, pp.45, 2160~2236
65. Forette F, "Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial", Lancet, 352, pp.1347~1351 (1998)
66. Peters R, "Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG)", Lancet Neurol, 7, pp.683~689 (2008)
67. van Dijk EJ, "Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences", Stroke, 39, pp.2712~2719 (2008)
68. James PA, "Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)", JAMA, 311, pp.507~520 (2014)
69. Sabayan B, "Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study", BMJ, 347, pp.f4600~ (2013)
70. Cooper C, "Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis", Am J Psychiatry, 171, pp.323~324 (2015)
71. Cai X, "Long-term anticholinergic use and the aging brain", Alzheimers Dement, 9, pp.377~385 (2013)
72. Mitchell AJ, "Rate of progression of mild cognitive impairment to dementia", Acta Psychiatr Scand, 119, pp.252~265 (2009)